Sortera Bio
Quantitative sequence to function at library scale.
$10.14M Pre Seed ·
Led by Cambridge Innovation Capital · Source: businessweekly.co.uk
Funding history ↓About Sortera Bio
Recent Funding lists Sortera Bio under Health and bio. It raised $10.14M in a Pre Seed round in June 2025, led by Cambridge Innovation Capital, according to businessweekly.co.uk. Investors on record include AstraZeneca and BioNTech.
Funding rounds
- Pre Seed · $10.14MSource: businessweekly.co.uk
- Website created
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Other companies backed by Cambridge Innovation Capital
MMicrobiotica$47.69M Series B+ · Oct 2026
SSalience Labs$125M Series B+ · Oct 2026
CCMR Surgical$400M Series B+ · Oct 2026
TTRIMTECH Therapeutics$14M Seed · Jun 2026
SStorm Therapeutics$56M Series B+ · Apr 2026
TTrent AI$13M Seed · Apr 2026
Cambridge Innovation Capital portfolio →
Questions and sources
Sortera Bio: questions and answers
- How much has Sortera Bio raised?
- Sortera Bio has raised $10.14M in one sourced round on record (Pre Seed), announced June 4, 2025.
- Who invested in Sortera Bio?
- Investors on record for Sortera Bio: AstraZeneca, BioNTech and Cambridge Innovation Capital. Cambridge Innovation Capital led its latest sourced round.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/sortera-bio (get a free API key).